Raymond James Financial Services Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $233M | Sell |
2,589,585
-171,983
| -6% | -$14.5M | 0.31% | 64 |
|
|
2024
Q2 | $217M | Sell |
2,761,568
-91,281
| -3% | -$7.48M | 0.31% | 67 |
|
|
2024
Q1 | $249M | Buy |
2,852,849
+38,887
| +1% | +$3.32M | 0.37% | 55 |
|
|
2023
Q4 | $232M | Sell |
2,813,962
-33,163
| -1% | -$2.53M | 0.38% | 57 |
|
|
2023
Q3 | $223M | Buy |
2,847,125
+99,423
| +4% | +$8.32M | 0.4% | 50 |
|
|
2023
Q2 | $242M | Buy |
2,747,702
+128,254
| +5% | +$11M | 0.43% | 46 |
|
|
2023
Q1 | $211M | Buy |
2,619,448
+484,357
| +23% | +$39.5M | 0.4% | 50 |
|
|
2022
Q4 | $166M | Sell |
2,135,091
-64,424
| -3% | -$5.22M | 0.33% | 58 |
|
|
2022
Q3 | $178M | Buy |
2,199,515
+108,303
| +5% | +$9.73M | 0.4% | 49 |
|
|
2022
Q2 | $188M | Buy |
2,091,212
+45,897
| +2% | +$4.65M | 0.41% | 45 |
|
|
2022
Q1 | $227M | Buy |
2,045,315
+182,596
| +10% | +$19.3M | 0.43% | 42 |
|
|
2021
Q4 | $193M | Buy |
1,862,719
+9,124
| +0.5% | +$1.06M | 0.36% | 59 |
|
|
2021
Q3 | $232M | Buy |
1,853,595
+46,511
| +3% | +$6.02M | 0.47% | 39 |
|
|
2021
Q2 | $224M | Buy |
1,807,084
+45,665
| +3% | +$5.73M | 0.46% | 40 |
|
|
2021
Q1 | $208M | Buy |
1,761,419
+56,351
| +3% | +$6.6M | 0.47% | 38 |
|
|
2020
Q4 | $200M | Buy |
1,705,068
+36,964
| +2% | +$4.07M | 0.5% | 35 |
|
|
2020
Q3 | $173M | Buy |
1,668,104
+33,672
| +2% | +$3.38M | 0.49% | 37 |
|
|
2020
Q2 | $150M | Buy |
1,634,432
+108,199
| +7% | +$10.4M | 0.48% | 39 |
|
|
2020
Q1 | $138M | Buy |
1,526,233
+53,884
| +4% | +$5.73M | 0.6% | 29 |
|
|
2019
Q4 | $167M | Buy |
1,472,349
+125,636
| +9% | +$13.8M | 0.53% | 35 |
|
|
2019
Q3 | $146M | Buy |
1,346,713
+189,720
| +16% | +$19.8M | 0.53% | 34 |
|
|
2019
Q2 | $113M | Buy |
1,156,993
+805,989
| +230% | +$73.6M | 0.43% | 43 |
|
|
2019
Q1 | $32M | Buy |
351,004
+41,583
| +13% | +$3.72M | 0.13% | 170 |
|
|
2018
Q4 | $28.1M | Buy |
309,421
+20,468
| +7% | +$1.91M | 0.15% | 152 |
|
|
2018
Q3 | $28.4M | Buy |
288,953
+79,218
| +38% | +$7.32M | 0.13% | 161 |
|
|
2018
Q2 | $18M | Buy |
209,735
+18,187
| +9% | +$1.52M | 0.09% | 252 |
|
|
2018
Q1 | $15.4M | Buy |
191,548
+12,848
| +7% | +$1.06M | 0.09% | 259 |
|
|
2017
Q4 | $14.4M | Sell |
178,700
-9,078
| -5% | -$727K | 0.09% | 261 |
|
|
2017
Q3 | $14.6M | Buy |
187,778
+4,264
| +2% | +$354K | 0.09% | 250 |
|
|
2017
Q2 | $16.3M | Buy |
183,514
+10,781
| +6% | +$909K | 0.11% | 211 |
|
|
2017
Q1 | $13.9M | Sell |
172,733
-9,180
| -5% | -$717K | 0.11% | 229 |
|
|
2016
Q4 | $13M | Sell |
181,913
-97,564
| -35% | -$7.66M | 0.11% | 227 |
|
|
2016
Q3 | $24.1M | Sell |
279,477
-10,175
| -4% | -$887K | 0.22% | 107 |
|
|
2016
Q2 | $25.1M | Buy |
289,652
+18,851
| +7% | +$1.52M | 0.24% | 95 |
|
|
2016
Q1 | $20.3M | Buy |
270,801
+27,404
| +11% | +$2.06M | 0.23% | 101 |
|
|
2015
Q4 | $18.7M | Buy |
243,397
+37,105
| +18% | +$2.79M | 0.22% | 110 |
|
|
2015
Q3 | $13.8M | Buy |
206,292
+143,869
| +230% | +$10.6M | 0.23% | 106 |
|
|
2015
Q2 | $4.63M | Buy |
62,423
+19,205
| +44% | +$1.47M | 0.33% | 74 |
|
|
2015
Q1 | $3.37M | Buy |
43,218
+12,286
| +40% | +$931K | 0.16% | 157 |
|
|
2014
Q4 | $2.23M | Sell |
30,932
-19,319
| -38% | -$1.34M | 0.12% | 214 |
|
|
2014
Q3 | $3.11M | Buy |
50,251
+198
| +0.4% | +$12.6K | 0.17% | 145 |
|
|
2014
Q2 | $3.19M | Sell |
50,053
-30
| -0.1% | -$1.82K | 0.19% | 139 |
|
|
2014
Q1 | $3.08M | Buy |
50,083
+1,885
| +4% | +$110K | 0.18% | 146 |
|
|
2013
Q4 | $2.77M | Buy |
48,198
+10
| +0% | +$567 | 0.17% | 156 |
|
|
2013
Q3 | $2.57M | Sell |
48,188
-13,824
| -22% | -$744K | 0.17% | 156 |
|
|
2013
Q2 | $3.19M | Buy |
+62,012
| New | +$3.07M | 0.09% | 261 |
|
Other funds holding MDT
Raymond James Financial Services Advisors's MDT Position: Q3 2024 in Review
Raymond James Financial Services Advisors reduced its Medtronic (MDT) stake by 6.2% in Q3 2024, selling an estimated $14.5M and leaving 2,589,585 shares worth $233M. The position accounts for 0.31% of the portfolio, ranked #64.
Raymond James Financial Services Advisors first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $249M in Q1 2024. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.
- Raymond James Financial Services Advisors held 2,589,585 shares of Medtronic worth $233M as of Q3 2024.
- Raymond James Financial Services Advisors sold 171,983 Medtronic shares in Q3 2024, an estimated $14.5M.
- Medtronic made up 0.31% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #64 holding.
- Raymond James Financial Services Advisors first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
- Raymond James Financial Services Advisors's Medtronic position peaked at $249M in Q1 2024.
- 2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.